"Double-Hit" Mature B-Cell Lymphomas Show a Common Immunophenotype by Flow Cytometry That Includes Decreased CD20 Expression

被引:55
作者
Wu, David [1 ]
Wood, Brent L. [1 ]
Dorer, Russell [2 ]
Fromm, Jonathan R. [1 ]
机构
[1] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA
[2] Virginia Mason Med Ctr, Dept Pathol, Seattle, WA 98101 USA
关键词
Flow cytometry; c-MYC; Double-hit; Dual translocation; BCL2; BCL6; CD20; MYC REARRANGEMENTS; CD38; EXPRESSION; DOWN-REGULATION; T(14/18); FEATURES; PROGNOSIS; NEOPLASMS;
D O I
10.1309/AJCP7YLDTJPLCE5F
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Lymphomas with 2 translocations involving c-MYC and BCL2 or BCL6 are a subset of biologically aggressive mature B-cell lymphomas now frequently categorized under the entity of B-cell lymphoma, unclassifiable, with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma. We identified a cohort of these lymphomas in our databases and retrospectively reviewed corresponding in-house flow cytometric data to determine whether a common immunophenotype might be present. Herein we report on our findings on 10 lymphomas, each with translocations involving c-MYC and BCL2 or BCL6 and show that these cases frequently showed a common immunophenotype that includes decreased expression of CD20. Because these lymphomas often show aggressive biologic behavior and poor clinical outcome, recognition of this relatively common immunophenotype may be useful for identifying cases for confirmatory cytogenetic studies, as often, flow cytometry provides the first assessment of these clinical specimens.
引用
收藏
页码:258 / 265
页数:8
相关论文
共 19 条
[1]   Flow cytometric immunophenotyping for hematologic neoplasms [J].
Craig, Fiona E. ;
Foon, Kenneth A. .
BLOOD, 2008, 111 (08) :3941-3967
[2]   Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels [J].
Czuczman, Myron S. ;
Olejniczak, Scott ;
Gowda, Aruna ;
Kotowski, Adam ;
Binder, Arvinder ;
Kaur, Harman ;
Knight, Joy ;
Starostik, Petr ;
Deans, Julie ;
Hernandez-Ilizaliturri, Francisco J. .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1561-1570
[3]   First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial [J].
Hagenbeek, Anton ;
Gadeberg, Ole ;
Johnson, Peter ;
Pedersen, Lars Moller ;
Walewski, Jan ;
Hellmann, Andrzej ;
Link, Brian K. ;
Robak, Tadeusz ;
Wojtukiewicz, Marek ;
Pfreundschuh, Michael ;
Kneba, Michael ;
Engert, Andreas ;
Sonneveld, Pieter ;
Flensburg, Mimi ;
Petersen, Jorgen ;
Losic, Nedjad ;
Radford, John .
BLOOD, 2008, 111 (12) :5486-5495
[4]   Commentary on the WHO classification of tumors of lymphoid tissues (2008): gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma" [J].
Hasserjian R.P. ;
Ott G. ;
Elenitoba-Johnson K.S.J. ;
Balague-Ponz O. ;
de Jong D. ;
de Leval L. .
Journal of Hematopathology, 2009, 2 (2) :89-95
[5]   Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance [J].
Hiraga, Junji ;
Tomita, Akihiro ;
Sugimoto, Takumi ;
Shimada, Kazuyuki ;
Ito, Masafumi ;
Nakamura, Shigeo ;
Kiyoi, Hitoshi ;
Kinoshita, Tomohiro ;
Naoe, Tomoki .
BLOOD, 2009, 113 (20) :4885-4893
[6]   Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival [J].
Johnson, Nathalie A. ;
Savage, Kerry J. ;
Ludkovski, Olga ;
Ben-Neriah, Susana ;
Woods, Ryan ;
Steidl, Christian ;
Dyer, Martin J. S. ;
Siebert, Reiner ;
Kuruvilla, John ;
Klasa, Richard ;
Connors, Joseph M. ;
Gascoyne, Randy D. ;
Horsman, Douglas E. .
BLOOD, 2009, 114 (11) :2273-2279
[7]   Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival [J].
Johnson, Nathalie A. ;
Boyle, Merrill ;
Bashashati, Ali ;
Leach, Stephen ;
Brooks-Wilson, Angela ;
Sehn, Laurie H. ;
Chhanabhai, Mukesh ;
Brinkman, Ryan R. ;
Connors, Joseph M. ;
Weng, Andrew P. ;
Gascoyne, Randy D. .
BLOOD, 2009, 113 (16) :3773-3780
[8]   Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis [J].
Kanungo, A ;
Medeiros, LJ ;
Abruzzo, LV ;
Lin, P .
MODERN PATHOLOGY, 2006, 19 (01) :25-33
[9]   The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement [J].
Le Gouill, Steven ;
Talmant, Pascaline ;
Touzeau, Cyrille ;
Moreau, Anne ;
Garand, Richard ;
Juge-Morineau, Nadine ;
Gaillard, Fanny ;
Gastinne, Thomas ;
Milpied, Noel ;
Moreau, Philippe ;
Harousseau, Jean Luc ;
Avet-Loiseau, Herve .
HAEMATOLOGICA, 2007, 92 (10) :1335-1342
[10]   High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis [J].
Lin, Pei ;
Medeiros, L. Jeffrey .
HAEMATOLOGICA, 2007, 92 (10) :1297-1301